NCT02777723

Study to Evaluate the Efficacy and Safety of CKD-350

Active Controlled, Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-350 Eye Drops in Patients With Dry Eye Syndrome

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 138 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the efficacy and safety of CKD-350 in patients with dry eye syndrome

Detailed description

Active controlled, randomized, double-blind, multi-center, phase 3 trial to evaluate the efficacy and safety of CKD-350 eye drops in patients with dry eye syndrome

Conditions

• Dry Eye Syndrome

Interventions

Type	Name	Description
DRUG	Xenobella	Hypotonic 0.3% Sodium Hyaluronate
DRUG	Isotonic 0.3% Sodium Hyaluronate	Isotonic 0.3% Sodium Hyaluronate

Timeline

• Start date: 2016-05-01
• Primary completion: 2016-07-01
• Completion: 2016-09-01
• First posted: 2016-05-19
• Last updated: 2016-05-19

Locations

14 sites across 1 country: South Korea